NIH experts discuss SARS-CoV-2 viral variants
Editorial emphasizes need for global response The rise of several significant variants of SARS-CoV-2, the virus that causes COVID-19, has…
Editorial emphasizes need for global response The rise of several significant variants of SARS-CoV-2, the virus that causes COVID-19, has…
NIH study compares how different face masks affect humidity inside the mask Masks help protect the people wearing them from…
A small pilot study suggests that early administration of ivermectin can reduce viral loads and symptom duration in patients with…
In a study evaluating the BioNTech-Pfizer COVID-19 vaccine’s ability to neutralize the B.1.1.7 (“UK”) viral variant, researchers found no loss…
The COVID-19 pandemic raises important questions about the role of life sciences in society and if the voices of scientists…
Researchers at Radboud university medical center have discovered an as yet unknown effect of hydroxychloroquine. It inhibits the action of…
Some patients with COVID-19 have persistent skin-related symptoms long after their initial infection has cleared, according to a new analysis….
Some COVID-19 patients experience long-lasting skin symptoms that vary according to type of COVID-19 skin rash, a late-breaking abstract will…
In March, in the early days of the coronavirus pandemic in Europe, a tweet from the French Health Minister, Olivier…
A new meta-analysis of published studies into the drug hydroxychloroquine shows that it does not lower mortality in COVID-19 patients,…
There’s considerable controversy over whether “COVID toes”–red sores or lesions on the feet and hands in children and young adults–are…
The Innovation Center of NanoMedicine (President: Prof. Kazunori Kataoka, location: Kawasaki in Japan; abbreviation: iCONM) initiated a collaborative study with…
A study of electronic medical records from US Veterans Health Administration medical centers has found that hydroxychloroquine–with or without azithromycin–did…
Since the World Health Organization declared COVID-19 a Public Health Concern of Global Interest on January 30, more than one…